Answer
Emmanuelle Charpentier, along with Jennifer Doudna, proposed the revolutionary CRISPR-Cas9 gene-editing tool in 2012. This discovery allows precise editing of DNA sequences, offering immense potential in fields such as biotechnology, agriculture, and even the treatment of genetic diseases. Its significance has been recognized, with the duo being awarded the Nobel Prize in Chemistry in 2020.